• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺 mpMRI、MR-US 融合活检与全器官切片病理检查的全面比较。

A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology.

机构信息

Department of Urology, Barmherzige Schwestern Krankenhaus, Vienna, Austria.

Medical Department II, Barmherzige Schwestern Krankenhaus, Vienna, Austria.

出版信息

World J Urol. 2023 Apr;41(4):1055-1060. doi: 10.1007/s00345-023-04339-6. Epub 2023 Feb 25.

DOI:10.1007/s00345-023-04339-6
PMID:36840753
Abstract

OBJECTIVES

To compare multiparametric magnetic resonance imaging (mpMRI) findings, US-MR fusion prostate biopsy results and whole-mount thin-section histopathology after radical prostatectomy.

PATIENTS AND METHODS

Overall 259 patients, who had undergone mpMRI with lesions reported as PI-RADS 3-5, underwent a MR-US fusion biopsy between 2018 and 2020. Overall 186 biopsies yielded prostate cancer and 104 patients subsequently underwent endoscopic extraperitoneal radical prostatectomy. Histopathology of biopsies was compared to the final histopathology in whole mount thin sections after radical prostatectomy by means of descriptive statistics, and further, the lesions from mpMRT were compared to whole mount histology.

RESULTS

Prostate cancer was diagnosed in 186 (71.8%) of 259 patients (median age 69.2 y, range 42-82 y, median PSA 7.8 ng/ml, range 2.1-31.3 ng/ml). Of those, 95 (51,1%) underwent radical endoscopic prostatectomy, and 80 (43%) chose radiotherapy or active surveillance. In 52/95 (54,7%) with RPE additional lesions were found in the final histological whole mount sections not described at mpMRI. 22/95 (23,2%) of RPE patients had ≥ 1 additional Gleason score ≥ 7 lesions, 23 /259 (8,4%) of biopsies, respectively. The Gleason score after surgery was upgraded in 37/95 (38,9%) and downgraded in 18/95 (18,9%) patients.

CONCLUSION

If we compare all 259 performed biopsies with the final histological whole mount sections which showed additional lesions with Gleason ≥ 7 (23,2%), it can be assumed that up to 10% of clinical significant carcinomas are missed during primary assessment via mpMRI. The majority of additional findings after RP were intermediate/high risk tumors. Upgrades from low-risk to intermediate or high-risk occurred.

摘要

目的

比较多参数磁共振成像(mpMRI)结果、磁共振超声融合前列腺活检结果和根治性前列腺切除术后全切片薄组织病理学。

患者和方法

共有 259 例患者接受了 MRI 检查,病变报告为 PI-RADS 3-5,2018 年至 2020 年间进行了磁共振超声融合活检。186 例活检发现前列腺癌,104 例患者随后行经腹腹腔镜根治性前列腺切除术。通过描述性统计比较活检的组织病理学与根治性前列腺切除术后全切片薄组织学的最终组织病理学,并进一步比较 mpMRI 的病变与全切片组织学。

结果

259 例患者中有 186 例(71.8%)诊断为前列腺癌(中位年龄 69.2 岁,范围 42-82 岁,中位 PSA 7.8ng/ml,范围 2.1-31.3ng/ml)。其中 95 例(51.1%)行根治性内镜前列腺切除术,80 例(43%)选择放疗或主动监测。在 52/95 例(54.7%)接受 RP 的患者中,在最终的全切片组织学中发现了 mpMRI 未描述的额外病变。95 例(23.2%)接受 RP 的患者中 Gleason 评分≥7 的额外病变≥1 处,而在 259 例活检中,分别有 23 例(8.4%)患者有 Gleason 评分≥7 的额外病变。术后 Gleason 评分升级 37 例(38.9%),降级 18 例(18.9%)。

结论

如果我们将所有 259 例活检与最终的全切片组织学进行比较,发现 Gleason≥7 的额外病变(23.2%),那么在原发性评估期间,通过 mpMRI 可能会漏诊高达 10%的有临床意义的癌。RP 后大多数额外发现为中高危肿瘤。发生了从低危到中危或高危的升级。

相似文献

1
A comprehensive comparison between mpMRI of the prostate, MR-US fusion biopsy and whole mount histopathology.前列腺 mpMRI、MR-US 融合活检与全器官切片病理检查的全面比较。
World J Urol. 2023 Apr;41(4):1055-1060. doi: 10.1007/s00345-023-04339-6. Epub 2023 Feb 25.
2
Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.在多参数磁共振成像上具有临床显著意义的前列腺癌患者中检测 Gleason 6 前列腺癌。
Clin Hemorheol Microcirc. 2019;73(1):105-111. doi: 10.3233/CH-199223.
3
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.多参数磁共振成像(MRI)和 MRI-经直肠超声融合活检用于检测起始肿瘤:与根治性前列腺切除术标本的相关性。
Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.
4
Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.在MRI/超声融合活检确诊的前列腺癌患者中,将多参数磁共振成像(MRI)结果与最终组织病理学结果进行直接比较。
BJU Int. 2016 Aug;118(2):213-20. doi: 10.1111/bju.13461. Epub 2016 Apr 2.
5
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.经会阴模板引导式饱和与靶向前列腺活检的男性前列腺癌检出率。
Prostate. 2022 Feb;82(3):388-396. doi: 10.1002/pros.24286. Epub 2021 Dec 16.
6
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.磁共振成像-经直肠超声图像融合活检能准确描绘出目标肿瘤:与 135 例患者的分段式根治性前列腺切除术标本的相关性。
Eur Urol. 2015 Apr;67(4):787-94. doi: 10.1016/j.eururo.2014.08.077. Epub 2014 Sep 17.
7
Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology.多参数 MRI 和靶向活检检测不良病理(筛状格里森 4 级和导管内癌)的敏感性:全切除组织病理学检测到和漏诊的前列腺癌病灶的相关性。
Urol Oncol. 2022 Oct;40(10):452.e1-452.e8. doi: 10.1016/j.urolonc.2022.07.012. Epub 2022 Aug 23.
8
Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer.术前多参数磁共振成像和 MRI/US 融合引导前列腺活检检测到单侧病变不是前列腺癌局部治疗的合适指征。
Urol Oncol. 2021 Oct;39(10):730.e17-730.e22. doi: 10.1016/j.urolonc.2021.04.021. Epub 2021 Jun 24.
9
Central zone lesions on magnetic resonance imaging: Should we be concerned?磁共振成像上的中央区病变:我们应该担心吗?
Urol Oncol. 2017 Jan;35(1):31.e7-31.e12. doi: 10.1016/j.urolonc.2016.08.006. Epub 2016 Sep 28.
10
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.多参数磁共振成像用于确认低风险前列腺癌主动监测计划的入选资格:第三家高转诊量中心主动监测方案的中期结果
Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

引用本文的文献

1
Comparison of cognitive magnetic resonance-ultrasonography fusion prostate biopsy outcomes in left lateral decubitus vs lithotomy positions: a prospective randomized study cognitive magnetic resonance-ultrasonography fusion prostate biopsy.左侧卧位与截石位认知磁共振-超声融合前列腺穿刺活检结果的比较:一项关于认知磁共振-超声融合前列腺穿刺活检的前瞻性随机研究
Int Urol Nephrol. 2025 May 3. doi: 10.1007/s11255-025-04544-9.
2
Impact of Discordance Between Magnetic Resonance Imaging and Ultrasound Volume Measurements on Prostate Fusion Biopsy Outcomes.磁共振成像与超声体积测量不一致对前列腺融合活检结果的影响。
J Urol. 2025 Apr;213(4):428-436. doi: 10.1097/JU.0000000000004368. Epub 2024 Dec 10.
3

本文引用的文献

1
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling.靶向前列腺活检:Umbra、Penumbra 和肿瘤边缘区采样的价值。
Eur Urol. 2022 Sep;82(3):303-310. doi: 10.1016/j.eururo.2022.01.008. Epub 2022 Feb 1.
2
Head-to-Head Comparison of Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.基于组织病理学金标准的 Ga-PSMA-11 PET/CT 与 mpMRI 对头对头比较在原发性前列腺癌的检测、前列腺内定位和局部扩展中的应用:一项前瞻性单中心成像试验的结果。
J Nucl Med. 2022 Jun;63(6):847-854. doi: 10.2967/jnumed.121.262398. Epub 2021 Oct 14.
3
"Seeing Is Believing": Additive Utility of Ga-PSMA-11 PET/CT in Prostate Cancer Diagnosis.
“眼见为实”:镓-PSMA-11 PET/CT在前列腺癌诊断中的附加效用
Cancers (Basel). 2024 May 5;16(9):1777. doi: 10.3390/cancers16091777.
Association of Gleason score with PSA Values and Serum Testosterone Levels Measured Prior To Prostate Biopsy.
前列腺穿刺活检前测得的Gleason评分与前列腺特异性抗原(PSA)值及血清睾酮水平的相关性
J Coll Physicians Surg Pak. 2020 Apr;30(4):399-402. doi: 10.29271/jcpsp.2020.04.399.
4
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.影响多参数磁共振成像检测临床显著前列腺癌性能变异性的因素:系统文献回顾。
Eur Urol Oncol. 2020 Apr;3(2):145-167. doi: 10.1016/j.euo.2020.02.005. Epub 2020 Mar 17.
5
Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.3T 多参数磁共振成像检测前列腺癌不同部位的能力:与全器官病理的相关性。
Int J Clin Oncol. 2020 Apr;25(4):732-740. doi: 10.1007/s10147-019-01587-8. Epub 2019 Dec 2.
6
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.前列腺影像报告和数据系统指导委员会:PI-RADS v2 现状更新及未来方向。
Eur Urol. 2019 Mar;75(3):385-396. doi: 10.1016/j.eururo.2018.05.035. Epub 2018 Jun 13.
7
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.多参数 MRI 和 TRUS 活检在前列腺癌(PROMIS)中的诊断准确性:一项配对验证性研究。
Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20.
8
Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy.错失良机:系统活检通过磁共振成像/经直肠超声融合活检对前列腺癌的升级。
J Urol. 2017 Feb;197(2):327-334. doi: 10.1016/j.juro.2016.08.097. Epub 2016 Aug 28.
9
Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.在MRI/超声融合活检确诊的前列腺癌患者中,将多参数磁共振成像(MRI)结果与最终组织病理学结果进行直接比较。
BJU Int. 2016 Aug;118(2):213-20. doi: 10.1111/bju.13461. Epub 2016 Apr 2.
10
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.多参数磁共振成像(MRI)和 MRI-经直肠超声融合活检用于检测起始肿瘤:与根治性前列腺切除术标本的相关性。
Eur Urol. 2016 Nov;70(5):846-853. doi: 10.1016/j.eururo.2015.12.052. Epub 2016 Jan 19.